In Phase II data released this week, people taking a monthly dose of PF’3944 continued to lose more weight than those on a ...

None of the conventional wisdom applies when you're making a Super Bowl ad.

To counterbalance this, AI-driven predictive technology is helping clinicians to identify risk early enough for closer ...

Amgen is running a number of studies of its obesity drug, MariTide.

Planet Money went to the annual meeting of the American Economics Association, and we saw some fascinating papers presented ...

1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...

NEW YORK (AP) — The U.S. stock market sank in mixed trading on Tuesday, while gold and silver bounced higher after their ...

HONG KONG – Asia shares were mixed on Wednesday following Wall Street losses weighed down by technology stocks, while gold and silver continued to regain ground after a recent sell-off.

Neomorph begins human testing of a molecular glue therapy that selectively removes cancer-driving proteins, targeting clear cell renal cell carcinoma.

DelveInsight's Oncolytic Virus Competitive Landscape 2026 report provides comprehensive global coverage of pipeline oncolytic virus therapies across various stages of clinical development. The report ...

Asia shares were mixed on Wednesday following a retreat on Wall Street on selling of technology stocks, while gold and silver continued to regain ground after a recent sell-off.